AP211A - Synthetic polypeptides. - Google Patents

Synthetic polypeptides. Download PDF

Info

Publication number
AP211A
AP211A APAP/P/1991/000245A AP9100245A AP211A AP 211 A AP211 A AP 211A AP 9100245 A AP9100245 A AP 9100245A AP 211 A AP211 A AP 211A
Authority
AP
ARIPO
Prior art keywords
amino acid
leu
gly
ser
ala
Prior art date
Application number
APAP/P/1991/000245A
Other languages
English (en)
Other versions
AP9100245A0 (en
Inventor
Robert Vincent Fishleigh
Barry Robson
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Publication of AP9100245A0 publication Critical patent/AP9100245A0/xx
Application granted granted Critical
Publication of AP211A publication Critical patent/AP211A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/1991/000245A 1990-03-15 1991-03-14 Synthetic polypeptides. AP211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909005829A GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides

Publications (2)

Publication Number Publication Date
AP9100245A0 AP9100245A0 (en) 1991-04-30
AP211A true AP211A (en) 1992-10-21

Family

ID=10672665

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000245A AP211A (en) 1990-03-15 1991-03-14 Synthetic polypeptides.

Country Status (17)

Country Link
EP (1) EP0519986A1 (cs)
JP (1) JPH05505188A (cs)
CN (1) CN1054772A (cs)
AP (1) AP211A (cs)
AU (1) AU636735B2 (cs)
BR (1) BR9106159A (cs)
CA (1) CA2078220A1 (cs)
CS (1) CS68091A2 (cs)
FI (1) FI923800A0 (cs)
GB (1) GB9005829D0 (cs)
HU (1) HUT63179A (cs)
IL (1) IL97551A0 (cs)
MX (1) MX24890A (cs)
NZ (1) NZ237417A (cs)
OA (1) OA09671A (cs)
WO (1) WO1991013909A1 (cs)
ZA (1) ZA911886B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657590B2 (en) * 1991-11-04 1995-03-16 Dade International Inc. Synthetic peptides corresponding to portions of HIV-2 virus and methods of using in an improved assay
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
EP0633881B1 (en) * 1992-03-11 2003-10-29 Narhex Limited Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
US6511845B1 (en) 1992-08-07 2003-01-28 Alan R. Davis Methods for producing an immune response against HIV-1
ATE258188T1 (de) 1992-08-27 2004-02-15 Deakin Res Ltd Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE4402756A1 (de) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
CN1472314A (zh) * 2002-07-29 2004-02-04 清华大学 艾滋病病毒o型株的一个免疫学表位及其应用
CN100445296C (zh) * 2006-03-31 2008-12-24 浙江大学 多肽有机化合物及其在异种移植中的应用
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
GB201612108D0 (en) 2016-07-12 2016-08-24 Univ Strathclyde Preperation of non-ionic surfactant vesicles and variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
ATE87487T1 (de) * 1987-11-16 1993-04-15 Hoffmann La Roche Rekombinante hiv-2 polypeptide.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chemical Abstr., Vol. 111, 1989, 76041v; *
Chemical Abstr., Vol. 113, 1990, 168573q; *

Also Published As

Publication number Publication date
AU636735B2 (en) 1993-05-06
BR9106159A (pt) 1993-03-16
GB9005829D0 (en) 1990-05-09
ZA911886B (en) 1991-12-24
HUT63179A (en) 1993-07-28
NZ237417A (en) 1993-10-26
IL97551A0 (en) 1992-06-21
FI923800A7 (fi) 1992-08-24
MX24890A (es) 1993-12-01
EP0519986A1 (en) 1992-12-30
CN1054772A (zh) 1991-09-25
WO1991013909A1 (en) 1991-09-19
AU7467991A (en) 1991-10-10
FI923800L (fi) 1992-08-24
HU9202939D0 (en) 1992-12-28
CS68091A2 (en) 1991-12-17
OA09671A (en) 1993-05-15
JPH05505188A (ja) 1993-08-05
FI923800A0 (fi) 1992-08-24
AP9100245A0 (en) 1991-04-30
CA2078220A1 (en) 1991-09-16

Similar Documents

Publication Publication Date Title
CA2124953C (en) Peptides related to prion proteins
AP211A (en) Synthetic polypeptides.
RU2201421C2 (ru) Синтетический пептид hiv (варианты), иммуногенная композиция для индукции иммунного ответа против пептидов hiv, диагностический набор для определения hiv-специфичных антител
US6335017B1 (en) Compositions and methods for treating viral infections
US5840313A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
EP0550599B1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
WO1993021218A1 (en) Synthetic polypeptides derived from the hiv envelope glycoprotein
EP0693938B1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
AU2006200454B2 (en) Compositions and methods for treating viral infections
AU6655300A (en) Compositions and methods for treating infections
AU2006200455A1 (en) Compositions and methods for treating viral infections
AU2004208648A1 (en) Compositions and methods for treating infections